Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank63
5Y CAGR-34.1%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-34.1%/yr
Long-term compound
Percentile
P63
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 23.20% |
| 2024 | -4.85% |
| 2023 | 156.27% |
| 2022 | -189.90% |
| 2021 | -28.89% |
| 2020 | 187.31% |
| 2019 | 392.35% |
| 2018 | -32.78% |
| 2017 | 0.00% |